Vétoquinol: a profession, a passion
Vétoquinol is a family-owned, independent company exclusively and passionately devoted to improving animal health and encompasses research and development, manufacturing, marketing and sales of pharmaceutical and nutritional products. Our product lines are intended for both large (beef cattle, swine, chickens, horses, etc.) and small (cats, dogs) animals and include most therapeutic categories.
Vétoquinol is active in Europe, North America, Africa, the Middle-East and in Asia-Pacific, with subsidiaries in 22 countries bringing together 1400 people (as of November 30, 2008) and a distribution network covering more than 80 countries.
2007
Opening of R&D facility in St-Hyacinthe, Quebec.
2006
Stock exchange listing, in the Eurolist market of Euronext Paris (Compartment B, mnemonics: VETO; ISIN code FR0004186856).
2004
Debut of company’s new tag line: “A Sign of Passion”
2003
New research and development facility opens in Lure, France.
1999
Following the acquisition of J. Webster Laboratories in Canada, Vétoquinol is confirmed as a market leader in soluble powders.
1992
Acquisition of Austin/Dispar in Canada.
1990
Vétoquinol acquires Univet in the UK and creates Vétoquinol North America, Canada. They in turn acquire Multivet and MVE.
1980
R&D facility opened in Lure, France to provide technical support for Vétoquinol.
1962
Becomes “Vétoquinol S.A.” , exclusively devoted to animal health. Facilities transfer from Lure, Haute Saône to Magny-Vernois, France.
1933
Joseph Frechin develops the first quinoline-based veterinary product: Vétoquinol.